Bureaucrats, editor, reviewer, Administrators
5,246
edits
PROTECT AF: Difference between revisions
Jump to navigation
Jump to search
→Subgroup Analysis: edit
(published) |
(→Subgroup Analysis: edit) |
||
| Line 147: | Line 147: | ||
===Subgroup Analysis=== | ===Subgroup Analysis=== | ||
* HR with treatment in men was lower than that for women (p=0·03; all other interaction tests p>0·40). | * HR with treatment in men was lower than that for women (p=0·03; all other interaction tests p>0·40). | ||
** For men, HR=0.32 (95% CI | ** For men, HR=0.32 (95% CI 0.13–0.77) | ||
** For women, HR=1.47 (95% CI | ** For women, HR=1.47 (95% CI 0.52–4.11) | ||
No other significant subgroup effects were seen (including age, CHADS2 score, type of AF, LAA size, LVEF). This did not change with the publication of the follow up data in 2013. | No other significant subgroup effects were seen (including age, CHADS2 score, type of AF, LAA size, LVEF). This did not change with the publication of the follow up data in 2013. | ||
===Adverse Events=== | ===Adverse Events=== | ||